Key players in the label-free detection market focus on new product launches

The global label-freedetection market is expected to reach USD 1,311.2 million by 2022 from USD 872.2 million in 2017, at a CAGR of 8.5%. Innovations in label-free detection technologies, increasing drug discovery programs through research partnerships between pharmaceutical companies and academic institutes, and growth in the global pharmaceutical and biotechnology industries are factors driving the growth of this market. On the other hand, the high cost of instruments is likely to restrain the market growth to a certain extent. 

Browse 110 Market Data Tables and 39 Figures spread through 147 Pages and in-depth TOC on "Label-Free Detection Market".

http://www.marketsandmarkets.com/Market-Reports/label-free-detection-market-32435593.html 

The label-free detection market is consolidated in nature due to the presence of a large number of players. The key players in the market include General Electric (US), Danaher (US), Perkin Elmer (US), AMETEK (US), Roche (Switzerland), Corning (US), Hitachi (Japan), HORIBA (Japan), Shimadzu (Japan), TA Instruments (US), Mettler-Toledo (US), Spectris (Malvern PANalytical) (UK), BiOptix (US), Wyatt Technology (UK), ACEA BIO (US), Attana (Sweden), NanoTemper Technologies (Germany), Affinité Instrument (Canada), Nicoya Lifesciences (Canada), Applied Photophysics (UK), Biosensing Instrument (US), Unchained Labs. (US), BioNavis (Finland), Insplorion (Sweden), and LUMICKS (Netherlands).

The key strategy followed by most companies in the label-free detection market is product launches. This strategy accounted for the largest share of the overall growth strategies mapped from 2015 to 2017.

General Electric (US) accounted for the largest share in the label-free detection market in 2016. The company caters to the label-free detection market through its Research Tools segment. The company provides its products to pharmaceutical and biotechnology companies, hospitals and clinical diagnostic laboratories, universities, research institutions, government agencies, and environmental & process control industries. GE offers a range of products covering all segments in the label-free detection market. The company adopted product launches as its key strategy to maintain its competitive position in the market. For instance, in 2016, the company launched Biacore systems to enhance its product portfolio in the label-free detection market. 

Submit here for Speak to Analyst:-

https://www.marketsandmarkets.com/speaktoanalyst.asp?id=32435593

Danaher (US) accounted for the second-largest market share in the label-free detection market in 2016. The company offers a wide range of label-free detection systems through its subsidiaries Pall ForteBio and Molecular Devices. The company adopted product launches as its key strategy to maintain its significant position in the label-free detection market. The company’s end users include pharmaceutical and biotechnology companies, hospitals & clinical diagnostic laboratories, universities, research institutions, and government agencies. Danaher launched advanced products in the category of molecular interaction. For instance, in 2017, the company launched its next-generation Octet systems for biologics characterization.

PerkinElmer (US) accounted for the third-largest market share in the label-free detection market in 2016. The company is one of the leading players focusing on instruments on molecular analysis through thermodynamic studies and a broad range of consumables. It has a global presence and provides automated instruments to prominent end users. Its end users include pharmaceutical and biotechnology companies, academic and research institutes, hospitals and clinical diagnostic laboratories, universities, and government agencies.